These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Inhibition of bcr-abl and/or c-abl gene expression by small interfering, double-stranded RNAs: cross-talk with cell proliferation factors and other oncogenes. Ohba H, Zhelev Z, Bakalova R, Ewis A, Omori T, Ishikawa M, Shinohara Y, Baba Y. Cancer; 2004 Sep 15; 101(6):1390-403. PubMed ID: 15368327 [Abstract] [Full Text] [Related]
26. Down-regulation of p210(bcr/abl) by curcumin involves disrupting molecular chaperone functions of Hsp90. Wu LX, Xu JH, Huang XW, Zhang KZ, Wen CX, Chen YZ. Acta Pharmacol Sin; 2006 Jun 15; 27(6):694-9. PubMed ID: 16723087 [Abstract] [Full Text] [Related]
27. [Using real-time polymerase chain reaction to quantitate bcr-abl mRNA]. Liu JX, Liu JL, Wang GJ. Ai Zheng; 2006 Nov 15; 25(11):1447-9. PubMed ID: 17094919 [Abstract] [Full Text] [Related]
29. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia. Primo D, Flores J, Quijano S, Sanchez ML, Sarasquete ME, del Pino-Montes J, Gaarder PI, Gonzalez M, Orfao A. Br J Haematol; 2006 Oct 15; 135(1):43-51. PubMed ID: 16939497 [Abstract] [Full Text] [Related]
30. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. Ruan GR, Qin YZ, Chen SS, Li JL, Ma X, Chang Y, Wang YZ, Fu JY, Liu YR. Leuk Res; 2006 Sep 15; 30(9):1159-65. PubMed ID: 16507320 [Abstract] [Full Text] [Related]
31. Nuclear topography and expression of the BCR/ABL fusion gene and its protein level influenced by cell differentiation and RNA interference. Bártová E, Harnicarová A, Pacherník J, Kozubek S. Leuk Res; 2005 Aug 15; 29(8):901-13. PubMed ID: 15978941 [Abstract] [Full Text] [Related]
33. The modulation of radiation-induced cell death by genistein in K562 cells: activation of thymidine kinase 1. Jeong MH, Jin YH, Kang EY, Jo WS, Park HT, Lee JD, Yoo YJ, Jeong SJ. Cell Res; 2004 Aug 15; 14(4):295-302. PubMed ID: 15353126 [Abstract] [Full Text] [Related]
34. Cotreatment with apicidin overcomes TRAIL resistance via inhibition of Bcr-Abl signaling pathway in K562 leukemia cells. Park SJ, Kim MJ, Kim HB, Sohn HY, Bae JH, Kang CD, Kim SH. Exp Cell Res; 2009 Jul 01; 315(11):1809-18. PubMed ID: 19268463 [Abstract] [Full Text] [Related]
35. Abnormalities in glucose uptake and metabolism in imatinib-resistant human BCR-ABL-positive cells. Kominsky DJ, Klawitter J, Brown JL, Boros LG, Melo JV, Eckhardt SG, Serkova NJ. Clin Cancer Res; 2009 May 15; 15(10):3442-50. PubMed ID: 19401345 [Abstract] [Full Text] [Related]
37. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl. Gutiérrez-Berzal J, Castellano E, Martín-Encabo S, Gutiérrez-Cianca N, Hernández JM, Santos E, Guerrero C. Exp Cell Res; 2006 Apr 01; 312(6):938-48. PubMed ID: 16443220 [Abstract] [Full Text] [Related]
39. Expression of cyclins D1, D2, and D3 and Ki-67 in Leukemia. Jaroslav P, Martina H, Jirí S, Hana K, Petr S, Tomás K, Julius M, Cedrik H. Leuk Lymphoma; 2005 Nov 01; 46(11):1605-1612. PubMed ID: 16334487 [Abstract] [Full Text] [Related]